Patents/Assignees

Wuhan YZY Biopharma Co., Ltd.

2 patents in portfolio

US12331119utility2025
Modified Fc Fragment, Antibody Comprising Same, and Application Thereof
0 cites
US11639388utility2023
CD3 Antigen Binding Fragment and Application Thereof
0 cites